NAS
ELV icon

Nykredit A/S’s Elevance Health ELV Stock Holding History

Nykredit A/S’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Buy
+77,041
New +$28.6M 0.11% 159

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nykredit A/S's ELV Position: Q2 2026 in Review

Nykredit A/S opened a new position in Elevance Health (ELV) in Q2 2026: 77,041 shares worth $29.8M. The stake represents 0.11% of the portfolio and ranks #159 among its holdings.

1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Nykredit A/S held 77,041 shares of Elevance Health worth $29.8M as of Q2 2026.
  • Elevance Health was a new Nykredit A/S position in Q2 2026.
  • Elevance Health made up 0.11% of Nykredit A/S's portfolio in Q2 2026, its #159 holding.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.